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ABSTRACT 
Protein misfolding and aggregation are responsible for several human pathologies commonly 
known as protein misfolding diseases. The various examples of protein misfolding diseases 
are: Alzheimer disease, spongiform encephalopathy, diabetes type 2, serpin-deficiency 
disorder, Huntington disease, Parkinson disease, amyloid polyneuropathy, and several others. 
The current research work was carried out to investigate the potential of ZnO nanoparticle to 
prevent lysozyme aggregation. ZnO nanoparticles were synthesized by chemical precipitation 
method from Zinc acetate dihydrate and urea. The optical, morphological and structural 
properties of synthesized ZnO nanoparticles have been studied using UV-Vis 
spectrophotometer, SEM, DLS, XRD and EDS. UV-Vis spectroscopic study shows that ZnO 
nanoparticles have surface plasmon resonance at 375nm. DLS analysis shows the average 
size of synthesized ZnO nanoparticle to be 68 nm. The EDS analysis shows the elemental 
composition of synthesized ZnO naoparticles and XRD study confirms the wurtzite structure 
of ZnO nanoparticles. The lysozyme aggregation was prepared by heating the native 
lysozyme at 100
0
C. The effect of ZnO nanoparticles on the aggregation of lysozyme was 
studied. DLS analysis shows the mean size of the aggregates decreases with increasing 
concentration of ZnO nanoparticle (NP), which was further confirmed by SEM analysis. UV-
Vis and Fluorescence spectroscopic studies were performed to analyze the structural changes 
of lysozyme upon binding with nanoparticles. The Congo red assay was performed to study 
the formation of amyloid fibrils. 
Key words: Protein misfolding, Aggregation, Nanoparticles, Zinc oxide, Congo red assay 
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1. INTRODUCTION  
Proteins are the essential macromolecules for controlling most of the biological processes 
inside the cell. These proteins are synthesized on ribosome from the genetic informations that 
encoded in cellular DNA. After synthesis, these molecules fold into native structure to 
become more stable. There are some environmental factors which cause the misfolding of 
proteins.  The inability of a protein molecule to adopt or to remain in its native conformation 
is termed as protein misfolding. Protein misfolding is the basis of some disorders like: cancer, 
degenerative diseases, metabolic pathologies that affect human most severely. It helps in 
causing diseases by altering the bio-availability of essential protein, like cystic fibrosis or by 
forming fibrillar aggregates with β-structure. Indeed protein misfolding and aggregation are 
responsible for about 40 human diseases. The fibrillar structures are accumulated in liver, 
heart, spleen and the central nervous system etc. In that case they are referred as amyloidal 
fibrils.  
      Now a day’s nanotechnology has brought a great attention due to wide applications of 
nanoparticles in various fields of science and technology.  Nanotechnology has emerged as 
the fore front of science and technology for last few decades. Generally it involves the 
production of devices or materials whose at least one dimension is in   nanometre range i.e. 1-
100 nm. Metal oxide nanoparticles which are inorganic in nature have attracted much 
attention for last few decades because they can withstand harse process conditions. Among 
metal oxides TiO2, ZnO, MgO and CaO have drawn great attention for further studies as they 
are very safe to human beings and also for animals. The broad applications of nanoparticles 
are drug delivery, imaging and diagnosis. Due to its small size, nanoparticles possess high 
surface to volume ratio, which gives distinguishing features to nanoparticles.  
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Studies have shown that ZnO and silver nanoparticles have antibacterial and antifungal 
activity. The antimicrobial property of nanoparticles is determined by their size, shape, 
morphology, composition and crystallinity. Research are going on to synthesize nanoparticles 
,designing nanodevices and application of these in different fields like medical, environment, 
energy, information and communication, heavy industry and customer goods etc.    
     Generally there are two parts of nanoparticles: the core material and a surface modifier. 
The surface modifier is responsible for change in physiochemical properties of core 
materials. The core material may be composed of biological materials like phospholipids, 
lipids, lactic acid, chitosan, and dextran or may be formed of carbon, chemical polymers, 
silica or metals. Various chemical compounds, drugs, probs and proteins are attached to 
nanoparticle surface by the help of covalent bonds or by adsorption. 
      When the chemical compounds attach to nanoparticle surface, the physiochemical 
properties changes. Thus the functionality of nanoparticles is enhanced or changed. The 
efficiency of nanoparticles for any applications depends upon the physiochemical 
characteristics of core material and surface modifiers. The composition of core materials 
along with surface modifiers makes the nanoparticles biodegradable and biocompatible. 
When nanoparticles are used as drug carriers, questions may arise about the toxicity of 
nanoparticles and this toxicity of nanoparticles is reduced by modifying their surface 
properties. Detail information about the interaction of nanoparticles with different molecules 
are not well known, but the interaction of nanoparticles with protein has drawn great attention 
because protein are the only one biological molecule which are fundamental to the proper 
functioning of cells and organisms. 
        In our present investigation we have synthesised ZnO nanoparticles and their interaction 
with hen egg lysozyme aggregates were studied. ZnO nanoparticles were synthesized by 
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chemical precipitation method and detail characterizations were done by UV-Vis 
spectrophotometer, SEM, DLS, XRD and EDS. Then these nanoparticles were interacted 
with aggregated hen egg lysozyme. The conformational change of lysozyme was studied by 
DLS, SEM ,UV-Vis spectrophotometer, fluorescence and spectrophotometer .Congo red 
assay was done to confirm that the formed aggregates are not amyloids.  
1.1. Objectives 
 Synthesis of ZnO nanoparticles by  Chemical  precipitation  method 
  Detail Characterization of synthesized ZnO nanoparticles  
 Investigating the effect of ZnO nanoparticles on aggregated hen egg lysozyme. .      
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2. LITERATURE REVIEW   
2.1. The structure of proteins  
Proteins are biomolecules in which   amino acid chains are connected to each other by 
peptide bonds. Protein molecules are very diverse molecules and also vary in size from small 
peptides to large no of multimers. The common element which is present in every protein is 
the peptide backbone. This peptide backbone is formed by peptide bonds which link amino 
acid residues [1].According to the amino acids and their side chains, the variation of peptide 
backbone is observed. Generally 20 amino acids are there and they are grouped into different 
families basing on their side chains, such as acidic, basic, neutral and hydrophobic side 
chains.   The primary structure of protein is determined by its amino acid sequences. The 
polypeptide chains fold into secondary elements like helix, sheet and turns which determine 
the three dimensional structure of protein [1].   
2.2. Protein misfolding and aggregation 
The Newly synthesized linear amino acid chain folds into its unique three dimensional 
structures to become functional. This unique structure is called native structure of protein. 
Protein misfolding is a very general tendency of protein molecules which occurs 
continuously. Certain mutation and amino acid composition are responsible for protein 
misfolding. Protein misfolding also occurred due to environmental changes [2].Certain 
environmental changes like increase in temperature, high or low pH, elevated glucose, 
agitation and oxidative agents also cause protein misfolding. Due to these agents the protein 
molecule loss their native conformation [3].The process by which protein losses their native 
conformation is called denaturation. Generally denaturation causes unfolding and partial 
misfolding of protein molecule. Due to lake of arrangement the partially misfolded protein 
17 
 
becomes non-functional and unfolded state is thermodynamically unfavourable and unstable. 
The unfolded protein has a propensity to form aggregates, which has lower energy and more 
stability [4].  Amyloid conformation is one specific aggregated form of protein molecules 
arises from protein misfolding. Amyloid contains linear, unbranched protein molecules or 
fibrils. Contrary to fibrillar proteins like collagen triple helix and keratin, amyloid contains 
linear unbranched protein or peptide fibrils [5].The special features of amyloid fibrils is that it 
binds fluorescent probs like Congo red and thioflavin derivatives. They commonly share a 
common secondary composition [6]. 
 
                      Figure 1.Protein misfolding and aggregation (Reproduced from [1]) 
2.3. Protein misfolding diseases 
Protein misfolding diseases are group of disorders that contain aggregated protein. For last 
few years protein misfolding diseases have drawn great attention which are also classified as 
protein conformational disorder(PCD)[7].The various examples of protein misfolding 
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diseases are: Alzheimer disease, spongiform encephalopathy, diabetes type 2, Huntington 
disease, Parkinson disease, serpin-deficiency disorder, amyloid polyneuropathy, and several 
others. There are various similarities among these diseases at molecular levels [8]. 
2.4. Metal oxide nanoparticles 
Nanotechnology has been considered as an immensely developing field due its wide 
applications in different fields of science and technology. The widely applicable word 
῾Nano  is derived from a Greek word whose meaning is extremely small or dwarf [9].The 
nanotechnology  concept was first given by Physist Richard Feynman in his talk “There is 
plenty of room at the bottom”[10].Nanotechnology can be considered as a multidisciplinary  
field which includes research and development of technologies in different  field like 
nanotechnology, biotechnology, physics, chemistry and material science [9,11].The research 
on synthesis of nanoparticles  has drawn great attention due to their distinguishing  physical 
and chemical properties  than the macroscopic particles[12].The rapid development of 
innovative synthesis  protocols and various characterisation  techniques  are the clue points 
for rapid development of nanotechnology[13].Chemical and physical methods  have been 
developed for synthesis of different types of nanoparticles, but the nanoparticles developed in 
these methods  show poor morphology .Moreover these processes  use toxic chemicals and  
elevated temperature for synthesis purpose which  is toxic to environment[9,14].Biological 
synthesis methods are more favourable since these methods are  eco-friendly. 
2.5. Synthesis of nanoparticles 
Basing on the different applications of nanoparticles, different protocols have been designed 
for synthesis of nanoparticles [15].The different methods used for synthesis of nanoparticles 
are: 
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 Physical method 
 Chemical method 
 Biological method 
2.5.1. Physical method 
The physical method often called top-down approach which includes methods like diffusion, 
irradiation, thermal decomposition; arc discharge etc .The thermal decomposition method 
which is one of top-down approaches, used for the creation of monodisperse nanoparticles. In 
this method fatty acids are allowed to dissolve in hot NaOH solution and then mixed with 
metal salt solution. Then this solution results the formation of metal precipitates. Crystals and 
short wires of cupper are allowed to be enclosed in glass ampoules in diffusion method. Then 
it is sealed at low pressure followed by annealing at 500
0
c for 24 hours. Then the crystals are 
removed from ampoules and then cooled on a metallic plate at room temperature. In UV 
irradiation method, polycarbonate films are placed on glass microscope slide .Then this slide 
is exposed to UV radiation. Like above methods there are many methods used in top down 
approaches to synthesize metal nanoparticles [15]. 
2.5. 2.Chemical method 
 The chemical reduction method is an example of bottom up approach, used for synthesis of 
nanoparticles. In these methods different metal particles are reduced to form nanoparticles.  
Different metal particles used are sodium Borohydrate and sodium citrate etc [16].Other 
chemical reagents used are N,N-dimethylformamide(DMF)[9]poly(N-vinyl 
pyrrolidine(PVP),ethyl alcohol[10],tetra-n-tetra-fluroborate(TFATEB),CTAB[11]etc.   
2.5.3. Biological method 
   Green synthesis method has advantages over other methods adopted for synthesis of 
nanoparticles.It is cost effective and eco-friendly. Moreover there is no need of using high 
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pressure, temperature and toxic chemicals. Now a days nanoparticles are synthesized from 
various sources like bacteria and fungi, plant extract etc [9, 14]. 
2.6. Zinc oxide nanoparticles 
Zinc oxide is an inorganic compound having formula ZnO. This is a white powder generally 
insoluble in water. The structure of ZnO nanoparticles has been investigated computationally 
using new atomistic potentials. Mechanical properties like internal stress and adhesion 
characteristics are required to maintain patterning accuracy and durability for various 
applications of nanopartcles. The structure of ZnO is generally hexagonal wurtzite.Generally 
ZnO crystallizes into hexagonal wurzite and Zinc blend. 
2.7. Application of ZnO nanoparticles                
In recent years Zinc oxide has been considered as an important semiconductor having wide 
band gap (3.37 eV), and large exciton-binding energy (60 meV) [20]. ZnO has been preferred 
as a highly  multitasking metal oxide due to its unique optical and electrical properties[21].In 
many industrial areas such as solar cells, UV light-emitting devices, photocatalysts, gas 
sensors, pharmaceutical and cosmetic  industries ZnO nanoparticles have been widely used 
[22-26] .Moreover metal nanoparticles have surface Plasmon resonance properties in UV-
visible region ,nontoxic, self-cleansing[27].ZnO nanoparticles are also biocompatible to skin 
and having antimicrobial, dermatological  properties. ZnO nanoparticles are used in 
sunscreen because it act as a UV blocker[28].ZnO nanoparticles have strong resistance to 
microorganisms  and this property is due to the generation of reactive oxygen species on the 
surface of nanoparticles.  
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2.8. Synthesis of Zinc Oxide nanaoparticles 
There are several physical, chemical procedures for synthesis of ZnO nanoparticle in large 
quantities in a short period of time. Among them simple-solution based methods, chemical 
precipitation, sol gel, solvothermal/hydrothermal, electrochemical and photochemical 
reduction method are preferable methods.ZnO nanoparticles can be synthesized form plant 
leaf extract, bacteria, fungi and enzymes by using green synthesis methods. Green synthesis 
methods are eco-friendly approach and compatible for pharmaceutical and other biomedical 
applications because no toxic chemicals are used in these methods [29].   
2.9. Lysozyme 
Lysozyme is a protein of single chain polypeptide having 129 amino acids and having 
molecular mass of 14.307 kda and isoelectric point at 11.35.These amino acids are cross 
linked with four disulfide bridges. It has the property to catalyse β (1-4) linkages between N-
acetylmuraminic acid and N-acetyl-D-glucosamine residues which are present peptidoglycan 
and catalyse N-acetyl-D-glucosamine residues in chitodextrin [30].Lysozyme often used to 
lyse bacterial cells by hydrolysing peptidoglycan present in cell walls. Gram positive cells are 
more susceptible than gram negative bacteria for lysozyme hydrolysis since gram positive 
bacteria have high proportion of peptidoglycal in their cell wall. Gram negative bacteria have 
less susceptible due lack of high proportion of peptidoglycan in their cell wall. However the 
hydrolysis of these bacteria cells become more easy in the presence of EDTA that chelates 
metal ions present in outer bacterial membrane. This lysozyme is purified from chicken egg 
white then it is crystallized three times followed by dialysis and then supplied as lyophilized 
powder. It has been estimated that protein content by UV absorbance is 90% and rest of the 
content is buffer salts like sodium acetate and sodium chloride. Lysozyme has been used as 
lysing agent for the purification of plasmid DNA. The activity of lysozyme depends both on 
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P
H
 and ionic strength. The activity of lysozyme is stable over  a broad P
H
 , ranging from 6.0 
to 9.0.The activity of this enzyme observed maximal at P
H 
6.2 over a wide range of ionic 
strengths(0.02-0.100M) than at P
H
 9.2(0.01-0.06M). The inhibitor of lysozyme is 
indolderivatives; it binds and distorts the active site. Another inhibitor is imidazole which 
helps in the formation of a charge-transfer complex. Various surface active agents like 
sodium dodecyl sulphate, sodium dodecanate and dodecyl alcohol can also inhibit lysozyme.  
2.10. Nanoparticle protein interaction  
When nanoparticles enter into the body they interact with biological fluids like plasma 
.Nanoparticles in these physiological environment bind with proteins to form a coat which is 
known as ῾ rotein corona  .  It is important to understand how and why proteins are absorbed 
to nanoparticle surface because corona is the key factors which determine the fact of 
nanomaterials in vivo [31].The surface properties of nanoparticles determine the binding of 
nanoparticles with protein. The surface properties of nanoparticles are determined by 
characteristics of nanoparticles such as the shape, chemical composition, surface 
functionalization, angle of curvature, porosity and crystalinity, roughness and hydrophilisity 
or hydrophobicity etc. The important forces that are responsible for nanoparticle –protein 
interaction are Vander Walls forces, London dispersion forces, polarization and lone-pair 
electrons and hydrogen bond. The mathematical model of nanoparticle-protein interaction 
can be predicted by taking the assumption that all inter-molecular interaction has equal 
contribution [32]. 
     Nanodescriptors can be created using the adsorption coefficients of probe compounds. 
These nanodescriptors represent the contribution and relative strengths of each molecular 
interaction. As an example, this model helped to predict, for example the adsorption of 
various small molecules onto carbon nanotubes [32]. In summary, the affinity of 
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nanoparticles to biomolecules is determined by the contribution of multiple site of adsorption 
on the NPs surfaces (that are close to the amino-acids residues of the proteins), and the 
contribution of various forces that depend on the proteins and the type of nanoparticles. 
Predicting this kind of interaction could be very helpful in nanomedicine to eliminate certain 
type of nanoparticles based on their relative nanodescriptors [33].   
 
Figure2.  The Effects of NPs on proteins, and the forces of interactions. (Reproduced from [34]) 
   The nanoparticle-protein interaction study gives a brief and help in understanding the 
potential biological injuries like changes in protein fibrillation, loss of function like 
enzymatic activity impairment and exposure of new epitopes [34].  
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 2.10.1. Conformational changes of protein upon binding with nanoparticles 
The secondary structure of proteins changes when they bind to planar surface, but when they 
bind to nanoparticles there is no change in secondary structure. The proteins retain their 
original structure due to high curvature of nanoparticles. However a wide study in various 
surfaces of nanoprticles and proteins suggested that a disturbance of protein structure still 
happens. The unfolding kinetic studies of β-lactoglobin and lysozyme were done to study the 
conformational studies. It has been studied that when above proteins were absorbed onto 
silica nanoparicles, there was changes in secondary and tertiary structural level[35,36].From 
many studies it has been confirmed that when proteins are absorbed onto nanoparticles, there  
are loss of α-helical content, with or without increase in β-sheets[35,37]. 
       It has been studied that Bovine serum albumin (BSA) is a good model protein for protein 
conformational studies. At different pH BSA undergoes conformational changes. From the 
circular dicroism studies it has been found that when gold nanoparticles bind BSA ,there is 
decrease in α-helical structure and increase in β-sheets and turns and  it was also studied by 
Fourier transform infrared(FTIR) spectroscopy[35].In few cases the thermodynamic stability 
of the protein is decreased  when they are absorbed onto nanoparticle surfaces, but in most 
cases the native structure of protein does not change.[38].When the thermodynamic stability 
decreases the proteins become sensitive to denaturating agents like urea. If such problems 
occur then the structural changes of protein may lead to loss of biological function when they 
introduce inside the body. 
     Therefore it is very essential to study the protein nanoparticle interaction, to know which 
properties of nanoparticles are responsible for perturbation of protein conformation. In 
general it has been studied that structural changes of protein occur due to intrinsic properties 
of protein combined with various features of nanoparticles. Recent studies have suggested 
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that how the concentration of nanoparticles on the surface of protein influence the structure 
and function of protein [35, 36].  
2.10.2. The size of the nanoparticles influence the structure and function of 
proteins 
The surface curvature which is responsible for protein nanoparticle interaction is determined 
by size of the nanoparticles.The nanoparticles  having larger surface area  possess low surface 
curvature where as that of small size have high surface curvature. An experimental study of 
nanoparticle size influencing the structure and function of protein has been performed taking 
lysozyme silica nanoparticle conjugates [37].From this study it was concluded that smaller 
nanoparticles strongly favour native like protein structure due to which lysozyme has intrinsic 
enzyme activity. When lysozyme adsorbed onto nanoparticle surface there is reduction in 
both α-helical content and enzymatic activity of lysozyme.When RNase adsorbed on silica 
nanoparticles similar matter occurred. The thermodynamic stability of RNase decreases upon 
binding to silica nanoparticles [38]. 
     A simple model shown below explains the mechanism for the effect of different size of 
nanoparticles on protein surface. The greater perturbation of native protein occurred for 
larger nanoparticles, because larger nanoparticles provide larger surface area for contact of 
protein on surface of nanoparticles [38].  
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Figure 3.Interaction of RNase with different diameters of silica nanoparticles (Reproduced from 38) 
2.10.3. Conformational changes of protein affected by surface 
concentration 
When the proteins concentration are kept constant and the concentration of nanoparticles vary 
then different surface concentrations can be obtained. When there is high surface 
concentration of nanoparticles then more proteins are absorbed onto nanoparticles surface so 
that a crowed surface environment created which facilitate protein-protein interaction. During 
the nanoparticle-protein interaction different surface concentration of nanoparticles can be 
obtained by keeping the concentration of protein constant and varying the quantity of 
nanoparticles. More proteins are absorbed onto the nanoparticle surface when the surface 
concentration of nanoparticles will be more. Wu and colleagues suggested that both lysozyme 
and β-lactoglobulin unfold to a greater extent when the surface concentration of the silica 
nanoparticles was lower than when the concentration of protein was higher [34, 39].It has 
been suggested that the interaction between protein and hydrophobic surface of silica 
nanoparticles occurred at lower surface concentration. Concentration results in the reduction 
of net energy barrier to protein unfolding. From the above study we can conclude that 
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immobilizing enzymes at high packing density onto nanoparticles will lead to less loss of 
activity of enzyme than lower surface densities. 
2.10. 4.Chaperon activity of nanoparticles 
It was widely accepted that when proteins adsorbed onto nanoparticle surface, the structure of 
protein is perturbed to a varying extents. To improve the protein folding it is interested to 
know whether the nanoparticles act as a chaperon. The protein surface in native protein is 
generally rich in hydrophilic residues. The hydrophobic core of the protein is generally buried 
when the proteins found in native state. The outer surface or hydrophilic surface generally 
interacts with the aqueous environment. When protein unfolds the hydrophobic core is 
exposed which causes protein aggregation. In order to proper folding the protein need 
chaperons like GroEL and GroES, which bind to the unfolded protein and make them proper 
folding to native state [40, 41].Chaperons are generally used in biotechnology to create 
biologically active recombinant proteins [42].Two types of nanoparticles have been found to 
be having refolding capacity such like a nanogel and another is hydrogel. 
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3. MATERIALS AND METHODS 
3.1. Chemicals 
For all experimental studies pure and analytical grade chemicals were used. For synthesis of 
ZnO nanoparticles Zinc acetate, urea were purchased from sigma Aldrich Pvt Ltd.The 
chemicals required for protein aggregation studies such as hen egg  lysozyme, Congo red and 
other chemicals required for buffer preparation were also purchased from sigma Aldrich Pvt 
Ltd. 
3.2. Glassware and Apparatus 
All glass wares (Measuring cylinders, Beakers, Conical flasks, and Test tubes etc.) were 
purchased from Borosil, India. 
3.3. Synthesis of ZnO nanoprticles 
The Zinc oxide nanoparticles were synthesized by using chemical precipitation methods from 
Zinc acetate and urea as described by C R Bhattacharjee et al. (2011).Zinc acetate dehydrates 
and urea solutions were prepared in deionised water maintaining molar concentration of 0.1 
M each. The Zinc oxide and urea solutions were mixed in a beaker with volumetrically ratio 
of 1:4 respectively. The solution was magnetically stirred at room temperature for 
homogeneous solution. Then the solution was transferred into a round bottom flask. After 
sealing the flask it was heated at 115
0
c for 1.5 hour in a muffle furnace. A white precipitate 
was formed after the completion of reaction. The precipitate was centrifuged at 6000 rpm for 
10 min and washed in distil water to remove any absorbed chemicals or ions, so that there 
will be less possibility of agglomeration. Then the precipitate was dried at 100
0
c for 1 hour 
and then calcined in a muffle furnace at 350
0 
C for 1 hour. Then the resulting powered 
obtained was ZnO nanoparticles.    
30 
 
3.4. Characterization of ZnO nanoparticles 
3.4.1. DLS particle size analyser 
Dynamic light scattering (DLS) which is based on the laser diffraction method with multiple 
scattering techniques was employed to study the average particle size of ZnO nanoparticles. 
The prepared sample was dispersed in deionised water followed by ultra-sonication. Then the 
particle distribution in liquid was studied in a computer controlled particle size analyser 
(ZETA sizer Nanoseries,Malvern instrument Nano Zs). 
3.4.2. Scanning electron microscopy 
In this research work JSM-6480 LV SEM machine was employed to study the morphology of 
synthesized nanoparticles. The experiment was performed at an accelerating voltage of 20 
kV.   
3.4.3. UV-Vis spectroscopy 
The synthesized ZnO nanoparticles were characterised by Perkin-Elmer UV-Vis 
spectrophotometer, Lamda.35, to know the Plasmon resonance property of ZnO 
nanoparticles.First the ZnO nanoparticles sample was sonicated in an ultrasonicator for 
uniform dispersion and then the aqueous component was taken and analysed for Plasmon 
resonance property at room temperature. 
3.4.4. XRD and EDS methods 
In this research work Philips PAN analytical machine was employed for X-ray diffraction 
studies. The phase variety and grain size was determined in X-ray diffraction studies. The 
synthesized ZnO nano articles sam le was studies with CUKα radiation at voltage of 30 kV 
and current of 20 MA with scan rate of 0.04
0
/sec.  Different phases present in the prepared 
sam les were identified with search and match facility available in X′  ert high score 
31 
 
software. The particle size of the prepared samples were determined by using Scherrer′s 
equation as follows 
 
Where D is the crystal size, λ is the wavelength of X-ray, Ѳ is the Braggs angle in radians 
and B is the full width at half maximum of the peak in radians.  
      The study of elemental composition of sample was carried out by energy dispersive X-ray 
spectroscopy (EDS) with the machine SEM (JEOL JSM_5800). 
3.5. Preparation of Lysozyme Aggregation  
Hen egg lysozyme aggregates were prepared by heating the native protein lysozyme. In this 
study100μM of lysozyme solution was taken. Then it was heated in a water bath maintaining 
the temperature at 100
0
C. After heating, the native protein was unfolded as high temperature 
causes unfolding of protein. Then due to lake of proper environment the protein misfolded 
and formed aggregates.   
3.6. Interaction of ZnO nanoparticles with aggregated lysozyme  
During the cooling process of lysozyme aggregation , ZnO nano articles of 100 μM were 
added to the aggregated protein with various protein: nanoparticle ratios such as 5:1, 2:1, 1:1, 
1:2, 1:5, and a sample without nanoparticle was kept as control. The above prepared samples 
were incubated overnight at 37
0
C. The nanopartcle protein interaction was studied by particle 
size analyzer (DLS), scanning electron microscope, UV-Vis spectrophotometer, and 
fluorescence spectroscopy and zeta potential measurement. 
0.9
cos
D

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3.7. Characterization of protein nanoparticles conjugates 
3.7.1. DLS analysis 
The formation of protein nanoparticles conjugates were first studied by DLS analysis. Five 
samples were prepared with protein nanoprticles ratio of 5:1,2:1,1:1,1:2,1:5 etc and  a control 
sample of aggregated lysozyme without nanoparticles was prepared and all are incubated 
overnight at 37
0
 C. The samples were characterized by DLS particle size analyser to 
determine the average size of aggregated protein samples 
3.7.2. SEM analysis for protein nanoparticles conjugates 
For SEM analysis two samples were prepared; one is aggregated lysozyme and other is 
protein nanoparticle conjugate with 1:5 molar ratio and these are incubated overnight at 37
0
C 
.These samples were analysed by Jeol JSM-6480 LV SEM at an accelerating voltage of 20 
KeV. 
3.7.3. UV-Vis spectroscopic analysis 
Native lysozyme was dissolved in 0.01mM PBS buffer then the absorbance spectra were 
taken. Protein nanoparticle conjugates were prepared with  ratio of 5:1,2:1,1:1,1:2,1:5  and a 
control of only aggregated lysozyme was also prepared and all were incubated overnight at 
37
0 
C. Then UV-Vis spectra were taken for all samples with Perkin Elmer, Lamda-35.  
3.7.4. Fluorescence spectroscopic study   
Three samples of protein nanoparticles conjugates with ratio of 5:1, 1:1 and 1:5 were prepared and a 
control sample of aggregated protein was prepared and incubated overnight at 37
0
 C. Then 
fluorescence spectra of native lysozyme and above prepared samples were taken with perkin-Elmer 
LS-55- Luminescence spectrometer. Fluorescence spectra were measured by excitation at 295 nm and 
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emission at 310-430 nm. The fluorescence spectra of ZnO nanoparticles was taken in this range and 
found that ZnO nanoparticles do not exhibit fluorescence at 310-430 nm.  
3.7.5. Zeta potential measurements 
The protein nanoparticles conjugate samples were prepared with different ratio of protein 
nanoparticles such as 5:1, 2:1, 1:1, 1:2, 1:5 etc. Zeta potential measurements were taken for native 
lysozyme , aggregated lysozyme and for all protein nanoparticle conjugate samples. 
 3.7.6. Congo red assay 
The Congo red assay was performed to detect whether any amyloid fibrils were formed 
during the aggregation study of protein. A stock solution of Congo red having concentration 
of 100 μM was  re ared in 90% filtered 0.01 mM Phosphate buffer solution. The constituents 
of above buffer solution was (0.0027MKCl and 0.137M NaCl; pH 7.4) and 10 %( v/v) 
ethanol. The above solution was filtered three times using filter paper to remove any Congo 
red micelles. The protein nanoparticle conjugate samples were mixed with the solution of 
Congo red in  hos hate buffer to yield a final concentration of 10 μM .The Congo red- 
protein nanoparticle conjugate samples were incubated at room temperature for 15 minutes 
before spectral analysis. The control sample of Congo red without protein nanoparticle 
conjugates was also prepared. The concentration of Congo red was same as concentration 
used in protein nanoparticle conjugate samples. Then a preaggreegated protein samples 
without Congo red was prepared. The absorbance of all test samples and control was taken at 
541 nm and 403 nm. The following formula was applied to determine the concentration of 
CR band (i.e. Congo red-amyloid)  
CR-Aβ=At
541
/47,800-At
403
/68,300-Acr
403
/86200  
      Where CR stands for Congo red, Aβ stands for amyloid fibrils, At is the absorbance of 
test sample with CR, Acr is the absorbance of Congo red. The results were ex ressed as μg/ml 
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4. RESULTS AND DISCUSSION 
4.1. Synthesis and characterization of ZnO nanoparticles  
4.1.1. Synthesis of ZnO nanoparticles prepared by chemical precipitation     
 
Figure 4: Synthesized ZnO nanoparticles by chemical precipitation method 
The figure 4 shows the ZnO nanoparticles synthesized by chemical precipitation method 
according to the procedure discussed in ῾ material and method .The powder form of 
synthesized ZnO nanoparticles looks white in colour. 
4.2. Characterization of ZnO nanoparticles 
4.2.1. DLS particle size analyser 
The particle size distribution (PSD) of synthesized ZnO nanoparticles by chemical 
precipitation method is shown in figure 5 and 6.According to the graph the particle size 
distribution of ZnO nanoparticles ranges from10 nm100 nm. Form the DLS figure it is clear 
that the solution contains nanoparticles having various sizes which is according to SEM data.  
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Figure: 5: Particle size distribution of ZnO nanoparticles 
 
Figure 6: Statistics of particle size distribution of ZnO nanoparticles 
 4.2.2. SEM analysis of ZnO nanoparticles 
Figure 7 shows the SEM image of ZnO nanoparticles synthesized by chemical precipitation 
method. Most of the particles in the powder are within 100 nm in size, and showing low 
agglomeration rate. Most of the particles are spherical in shape.   
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Figure 7: SEM micrograph of ZnO nanoparticles at X 27,000  
4.2.3. UV-vis absorption studies   
  
Figure 8: UV-Vis spectra of the ZnO nanoparticles 
Figure 8 shows the UV-Vis absorption spectra of ZnO nanoparticles. The absorption spectra 
of ZnO nanoparticles shows peaks at 375 nm and this is due to the plasmon resonance of Zinc 
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oxide nanoparticles. The ZnO nanoparticles have distinctive colour in colloidal solution due 
to its tiny dimension. The electron cloud on the surface of nanoparticles oscillates and 
absorbs electromagnetic radiation at particular energy. The particular type of resonance arises 
is called surface Plasmon resonance. The shifting of absorption spectra towards red end or 
blue end depends upon the particle size, shape, surrounding medium and state of aggregation.   
4.2.4. XRD and EDS analysis  
 
Figure 9: XRD patterns of ZnO nanoparticles 
Figure 9 shows the XRD pattern of ZnO nanoparticles. The XRD pattern confirms the 
crystalline structure of ZnO nanoparticles. The picks of the diffractogram are well indexed to 
hexagonal phase of Zinc oxide powder. The synthesized ZnO powders are having wurtzite 
structure. Any peaks related to impurities are absent in diffractogram.  
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                                Figure-10: EDS micrograph of ZnO nanoparticles 
The figure 10 shows the EDS analysis of ZnO nanoparticles which confirms the elemental 
composition of ZnO nanoparticles. The  EDS analysis  display the optical absorption peaks of 
ZnO nanoparticles and these absorption peaks are due the surface Plasmon resonance of Zinc 
oxide nanoparticles.                       
4.3. Characterization of  nanoparticle protein conjugates 
4.3.1. DLS analysis  
 
Figure 11: Particle size distribution of native lysozyme 
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Figure 12: particle size distribution of aggregated lysozyme  
 
Figure 13: particle size distribution of protein nanoparticle sample (5:1) 
 
Figure 14: particle size distribution of protein nanoparticle sample (2:1) 
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Figure 15: particle size distribution of protein nanoparticle sample (1:1) 
Figure 16: particle size distribution of protein nanoparticle sample (1:2) 
Figure 17: particle size distribution of protein nanoparticle sample (1:5) 
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Figure 18: Average particle size of different samples of nanoparticle protein conjugates                 
The figures above show the DLS analysis of protein nanoparticle conjugates. The symbols 
NP and pro suggest for nanoparticles and protein respectively. Analysis suggests that solution 
containing only lysozyme shows average size of particles at 96 nm but aggregated protein 
shows high rate of agglomeration since the average size of particles in this solution has 
greater than others  (figure 12) .But as the concentration of nanoparticles increase in solution 
the rate  of aggregation decreases(Figure 13-17). This might indicates that nanoparticles have 
the potential to prevent aggregation of protein. The fig-15 shows the bar diagram which 
indicates the decrease in rate of aggregation with increasing the concentration of 
nanoparticles.       
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4.3.2. SEM analysis  
The lysozyme ZnO conjugates were also studied by SEM analysis. Figure-19 shows the SEM 
micrograph of aggregated lysozyme. It can be conclude that after the native structure was lost 
the   protein misfolds and then aggregates. When we introduce nanoparticles (with protein 
nanoparticle ratio of (1:5), the nanoparticles bound to the aggregated protein and then 
prevented the rate of aggregation. This result has been shown clearly in figure 20. So it can 
be concluded that ZnO nanoparticles prevent the rate of aggregation of lysozyme.            
 
 
Figure: 19 SEM image showing the aggregated lysozyme 
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Figure: 20 SEM image showing the prevention of aggregation by ZnO nanoparticles. 
 4.3.3. UV-Vis spectroscopy analysis 
 
Figure 21: UV-Vis spectra of lysozyme dissolved in 0.01 mM PBS buffer 
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.              Figure 22: UV-Vis spectra of ptotein nanoparticle solutions 
The figure 21 shows the absorbance spectra of lysozyme in 0.1mM PBS buffer. The peak of 
the curve found to be at 204 nm .The ZnO nanoparticles induced conformational changes of 
lysozyme is represented in figure 22. From the figure 22, curve a represents the curve for 
aggregated lysozyme. From the figure it can be conclude that after heating there is loss of 
native structure of lysozyme, which may indicate that lysozyme losses activity after heating. 
The absorption spectra for aggregated protein shows peak about at 275 nm. The curve 
suggests that after unfolding of lysozyme, the tryptophan comes out which gives absorbance 
spectra at 275 nm. The curves b to f represents the reduction in absorbance but no shifting in 
peaks. It may be suggested that nanoparticles prevent the aggregation of lysozyme.   
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4.3.4. Fluorescence spectroscopy analysis   
 
Figure 23: Fluorescence emission spectra of Lysozyme and lysozyme nanoparticle conjugates at 
different concentration of lysozyme and nanoparticles 
 The effect of ZnO nanoparticles on aggregated lysozyme was studied by using Tryptophan 
fluorescence. In the figure 23 curve a shows the fluorescence emission spectra for native 
lysozyme dissolved in 0.01mM PBS buffer. It reveals that the protein in native stage has 
λmax at approximately 340 nm. In the presence of ZnO nanoparticles, the λmax shifted to 
about 350 nm. This reveals the change in tertiary structure of lysozyme upon misfolding. 
When nanoparticles are introduced there is reduction in tryptophan florescence intensity 
.When nanoparticles bind with protein molecule, brings down the fluorescence intensity of 
tryptophan which indicate a havoc conformational change of protein molecule. This may be 
concluded that upon binding with nanoparticles the tryptophan molecules are transferred to 
more polar environment. So in presence of nanoparticles the tryptophan fluorescence was 
quenched drastically.                      
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4.3.5. Zeta potential measurements 
Figure 24: Zeta potential distribution of native lysozyme            
          Figure 25: Zeta potential distribution of aggregated lysozyme 
  
Figure 26: Zeta potential distribution of protein-nanoparticle solution (5:1) 
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Fig
ure 27: Zeta potential distribution of protein-nanoparticle solution (2:1) 
Figure 28: Zeta potential distribution of protein-nanoparticle solution (1:1) 
 
Figure 29: Zeta potential distribution of protein- nanoparticle solution (1:2) 
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Figure 30: Zeta potential distribution of protein-nanoparticle solution (1:5)  
The Zeta potential analysis was done for native lysozyme and also for aggregated  lysozyme 
with and without different concentration of nanoparticles.The analysis shows that the native 
lysozyme solution is more stable having high value of zeta potential compared to 
others(figure 24).When  the protein misfolds it leads to agglomeration causing protein to be 
unstable which have low value of zeta potential(figure 25).When the nanoparticles are 
introduced the value of zeta potential increases corresponding to the concentration of 
nanoparticles added. From the above figures(26-30) it is clear that the value of zeta potential 
increases for samples 5:1,2:1,1:1,1:2,1:5 respectively. Since the value of Zeta potential is 
increasing, it may be concluded that the nanoparticles are preventing aggregation of protein 
molecules, increasing the stability of protein molecule.   
4.3.6. Congo red assay  
The Congo red assay was done to measure the presence of any amyloid fibrils in the 
aggregated lysozyme protein solution, according to the protocol given in the materials and 
methods section. In the figures below, curve shows the absorbance spectra for Congo red. 
Then curve b shows the absorbance spectra of aggregated lysozyme with Congo red and 
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curves c,d,e,f and g show the absorbance spectra of  protein nanoparticles  solutions  having 
ratio of 5:1,2:1,1:1,1:2,1:5 respectively with Congo red. The absorbance of Congo red, 
aggregated lysozyme  and nanoparticle- aggregated lysozyme conjugate with Congo red were 
taken at 541 nm and 403 nm. Then the amount of amyloid fibrils was calculated according to 
the following formula given in materials and methods as follows 
CR-Aβ=At
541
/47,800-At
403
/68,300-Acr
403
/86200              
   From the figure it has been confirmed that the peaks obtained are same as without congo red (as 
figure 22).So it has been concluded that Congo red did not bind aggregated lysozyme. Since the 
congo red has the property to bind only amyloid fibrils, so there is no amyloid fibrils formation in the 
above solution (table 1).      
 
 
Figure 31: Absorbance spectra of Congo assay  
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 Table-1: Amyloid fibrils in protein nanoparticle solution (The results were expressed as μg/ml) 
Name of samples  ABS at 541 nm  ABS at 403 nm  Aβ fibrils (µg/mL)  
Congo red  0.083642  0.069936  -----  
Aggregated 
protein  
0.084510  0.070141  0  
Protein: NP (5:1)  0.084829  0.070137  0  
Protein: NP (2:1)  0.089769  0.075464  0  
Protein: NP (1:1)  0.99970  0.081472  0 
Protein: NP (1:2)  0.11221  0.084731  0 
Protein: NP (1:5)  0.095781  0.077694  0 
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5. CONCLUSION: 
Zinc oxide nanoparticles were successfully synthesized by using chemical precipitation 
method. The DLS analysis shows that the size of nanoparticles ranges from 10-100 nm. The 
UV-Vis spectroscopic study shows the Plasmon resonance property at 375 nm. The XRD 
study confirms the wurtzite structure of ZnO nanoparticles. The EDS analysis shows the 
elemental composition of ZnO nanoparticles. The effect of ZnO nanoparticles on aggregation 
of lysozyme was studied by various characterization techniques. The DLS and SEM analysis 
confirms the potential of ZnO nanoparticles to prevent the aggregation of hen egg lysozyme. 
The UV-Vis and fluorescence spectroscopy analysis suggest the conformational changes of 
lysozyme upon binding with ZnO nanoparticles. The Zeta potential measurement suggests 
that stability of aggregated lysozyme increases with increase in concentration of ZnO 
nanoparticles. From Congo red assay we confirm that there is no amyloid formation in our 
nanoparticle protein conjugate samples. Therefore it can be concluded that ZnO nanoparticles 
have the potential to prevent lysozyme aggregates. 
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